Earwax could offer clues of early Parkinson's disease, new study suggests
In particular, its odor could help clinicians detect the progressive neurological movement disorder, researchers noted in the study, which was published in the journal Analytical Chemistry.
Parkinson's is usually diagnosed after an individual demonstrates symptoms such as tremors, rigidity, bradykinesia (slowed movement), and gait changes, according to health experts.
The study suggested that volatile organic compounds (VOCs) — which are released by sebum (oily secretions that help lubricate and protect skin) in the ear wax of individuals with Parkinson's — have a certain distinctive smell.
The odor is the result of systemic inflammation, neurodegeneration, and oxidative stress related to disease progression, as noted in the report from the American Chemical Society.
'There is evidence that patients with Parkinson's disease produce excess sebum, and other research groups have demonstrated that there are particular chemical profiles of this sebum compared to patients without PD,' Dr. Joohi Jimenez-Shahed, medical director of movement disorders, neuromodulation and brain circuit therapeutics at the Icahn School of Medicine at Mount Sinai in New York City, told Fox News Digital.
(Jimenez-Shahed was not affiliated with the study.)
3 Earwax may provide an unexpected early warning of Parkinson's disease (PD), according to new research.
Peakstock – stock.adobe.com
In this recent study, researchers in China analyzed wax swabs from the ear canals of 209 participants, 108 of whom had been diagnosed with Parkinson's.
Using specialized methods to analyze chemicals in the wax, the investigators found that four of the VOCs in people with the disease were significantly different from those who had not been diagnosed, the study detailed.
They concluded that four VOCs — ethylbenzene, 4-ethyltoluene, pentanal, and 2-pentadecyl-1,3-dioxolane — may serve as potential biomarkers for PD.
The researchers used the collected earwax data to train an artificial intelligence olfactory (AIO) system, technology that uses sensors to simulate the human sense of smell to detect and analyze VOCs.
According to the report, the AIO system showed 94% accuracy with earwax samples from people with and without Parkinson's.
The study authors suggested that the AIO system could eventually be used as a first-line screening tool for early Parkinson's detection, allowing for earlier treatment of the disease.
Most current treatments only manage symptoms and help maintain quality of life, but don't stop or reverse the disease, which makes early diagnosis and treatment vital, according to the National Institute of Neurological Disorders and Stroke (NINDS).
The report also noted that current tests for Parkinson's — such as imaging studies and clinical rating scales — can be costly and subjective.
This potential detection system could provide an easy and inexpensive way to test for the disease, although experts pointed out that more testing is needed.
Limitations and future research
The study was performed on a small scale in a single clinic in China, according to Hao Dong, one of the study authors at the Research Center for Frontier Fundamental Studies in China.
3 The study suggested that volatile organic compounds — which are released by sebum in the earwax of individuals with Parkinson's — have a certain distinctive smell.
jaojormami – stock.adobe.com
'The next step is to conduct further research at different stages of the disease, in multiple research centers and among multiple ethnic groups, in order to determine whether this method has greater practical application value,' Dong said in a news release.
Jimenez-Shahed noted that ideally, this new method could serve as an early diagnostic test, potentially easier than using spinal fluid, skin biopsies, or specialized scans.
The above expert, who is also an associate professor of neurology and neurosurgery at the Icahn School of Medicine at Mount Sinai, cautioned that the particular profiles of ear wax VOCs reported in the recent study may differ from findings from other studies.
'There needs to be replication and/or expansion of sample size before determining the specific diagnostic potential of a test like this,' he added.
3 Parkinson's is usually diagnosed after an individual demonstrates symptoms such as tremors, rigidity, slowed movement, and gait changes, according to health experts.
highwaystarz – stock.adobe.com
Those who are concerned about potential Parkinson's risk should consult with a neurologist or movement disorder specialist, Jimenez-Shahed advised.
A specialist can carefully screen the individual for early warning signs and determine the need for further diagnostic testing or treatment.
The study was funded by the National Natural Science Foundation of Science, Pioneer and Leading Goose R&D Program of Zhejiang Province, and the Fundamental Research Funds for the Central Universities.
Fox News Digital reached out to the study authors for further comment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
2 days ago
- Newsweek
Parkinson's Breakthrough Could Help Prevent Brain Cell Loss
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A new treatment for one type of Parkinson's disease may be on the horizon after researchers discovered a "brake" that can halt cell death. The study, led by researchers from Stanford University, California, involved a form of the neurodegenerative disorder that is caused by a single genetic mutation. This mutation causes an excess of a protein that interferes with the brain's ability to protect itself. Inhibiting this protein, the team found, can halt the damage and even allow dying neurons to recover. "These findings suggest that it might be possible to improve, not just stabilize, the condition of patients with Parkinson's disease," said paper author and Stanford biochemist professor Suzanne Pfeffer in a statement. Key, however, will be "if patients can be identified early enough," she added. While Parkinson's most recognizable symptom might be resting tremors, the earliest signs of the disease typically manifest some 15 years earlier. These first signs, Pfeffer said, include constipation, a loss of smell and REM sleep behavior disorder, a condition in which people act out their dreams while sleeping. Artist's impression of neurons in the brain. Artist's impression of neurons in the brain. FlashMovie/iStock / Getty Images Plus In the U.S, it is estimated that some 1.1 million people are living with Parkinson's disease—a figure only expected to rise in the near future, according to the Parkinson's Foundation. As Pfeffer and colleagues explain, around a quarter of all cases are caused by genetic mutations, with one of the most common being one that increases the activity of an enzyme called leucine-rich repeat kinase 2 (LRRK2). Too much LRRK2 in the brain changes the structure of cells by causing them to lose their "antenna" (technically the primary cilia) that allows them to send and receive chemical messages. In a healthy brain, communications are relayed back and forth between dopamine neurons in two regions of the brain known as the striatum and the substantia nigra. When dopamine neurons are stressed, they release a protein-based signal in the striatum called sonic hedgehog (after the video game character)—this causes neurons and support cells to produce so-called neuroprotective factors that shield other cells from dying. When LRRK2 activity crosses a certain threshold, the loss of the primary cilia in the cells of the striatum prevents them from receiving the sonic hedgehog signal; as a result, the neuroprotective factors are not produced. "Many kinds of processes necessary for cells to survive are regulated through cilia sending and receiving signals," explained Pfeffer. "The cells in the striatum that secrete neuroprotective factors in response to hedgehog signals also need hedgehog to survive. "We think that when cells have lost their cilia, they are also on the pathway to death because they need cilia to receive signals that keep them alive." A diagram shows how neurons (blue) rooted in the substantia nigra provide dopamine (dark green dots) to striatal neurons (red). A diagram shows how neurons (blue) rooted in the substantia nigra provide dopamine (dark green dots) to striatal neurons (red). Emily Moskal / Stanford Medicine It is possible to combat an excess of LRRK2 using a so-called "MLi-2 LRRK2 kinase inhibitor," a molecule that attaches to the enzyme and reduces its activity. In their study, Pfeffer and colleagues set out to test whether this inhibitor could also reverse the effects of too much LRRK2, as well as whether it was even possible for fully mature neurons and supportive glia to regrow lost cilia and regain their communication ability. At first, the results were not promising. The team gave the inhibitor for two weeks to mice that had the LRRK2 mutation (and show symptoms consistent with early Parkinson's disease)—to no effect. However, the researchers were inspired by recent studies into sleep-wake cycles, which found that the primary cilia on the mature cells involved grew and shrank every 12 hours. "The findings that other non-dividing cells grow cilia made us realize that it was theoretically possible for the inhibitor to work," said Pfeffer. Inspired by this, the team decided to try giving the mice the inhibitor for a longer time—with the results at three months being "astounding," the biochemist added. The longer treatment saw the percentage of striatal neurons and glia with primary cilia in the mice with the mutation increase to the same level as regular, healthy mice. This had the effect of restoring communication between the dopamine neurons and the striatum, leading to the normal secretion of neuroprotective factors. The researchers also found that the level of hedgehog signaling from the dopamine neurons decreased—suggesting that they were under less stress. Moreover, the density of dopamine nerve endings in the mice's striatum was found to double, suggesting that neurons which had been in the process of dying had recovered. LRRK2 inhibition decreased stress in dopamine neurons in mice models of Parkinson's (top right vs. bottom right—with healthy mice on the left for comparison.) LRRK2 inhibition decreased stress in dopamine neurons in mice models of Parkinson's (top right vs. bottom right—with healthy mice on the left for comparison.) Ebsy Jaimon & Suzanne Pfeffer With their initial study complete, the researchers say that their next step would be to determine whether other forms of Parkinson's that are not associated with the LRRK2 mutation could also benefit from the new treatment. This is possible, Pfeffer explains, because the mutation is not the only way to end up with an overactive LRRK2 enzyme. In fact, she added, the inhibitor treatment might even help with other neurodegenerative diseases. "We are so excited about these findings. They suggest this approach has great promise to help patients in terms of restoring neuronal activity in this brain circuit, said Pfeffer. She concluded: "There are multiple LRRK2 inhibitor clinical trials underway—and our hope is that these findings in mice will hold true for patients in the future." Do you have a tip on a health story that Newsweek should be covering? Do you have a question about Parkinson's disease? Let us know via health@ Reference Jaimon, E., Lin, Y.-E., Tonelli, F., Antico, O., Alessi, D. R., & Pfeffer, S. R. (2025). Restoration of striatal neuroprotective pathways by kinase inhibitor treatment of Parkinson's disease–linked LRRK2-mutant mice. Science Signaling, 18(793).
Medscape
2 days ago
- Medscape
Earwax Secretions May Help Detect Parkinson's Disease
Odors from earwax may help distinguish individuals with Parkinson's disease (PD) from those without the condition, a new study suggests. Researchers found that four volatile organic compounds (VOCs) in ear canal secretions significantly differed between participants with and without PD. The compounds — ethylbenzene, 4-ethyltoluene, pentanal, and 2-pentadecyl-1,3-dioxolane — may represent potential biomarkers. An artificial intelligence olfactory (AIO)-based screening model used in the study identified those with PD with 94% accuracy. 'The accuracy of the model really surprised us,' study investigator Hao Dong, Research Center for Frontier Fundamental Studies, Zhejiang Lab, Hangzhou, China, MD, told Medscape Medical News . However, the study was a 'small-scale, single-center experiment,' he noted in a press release. 'The next step is to conduct further research at different stages of the disease, in multiple research centers, and among multiple ethnic groups in order to determine whether this method has greater practical application value,' Dong said. The findings were published online recently in Analytical Chemistry . Unique Odor Profile 'Our team has long been engaged in the detection of [VOCs] secreted by the human body. By chance, we came across reports on the detection of sebum VOCs for Parkinson's,' Dong said. Sebum, the oily substance secreted by the skin, may carry a distinct scent in individuals with PD. In a 2019 study cited by Dong, researchers noninvasively collected sebum samples from the upper backs of 64 participants. The findings suggested that samples from those with PD contained compounds associated with a unique odor profile. Dong and his team began with a confirmatory experiment using sebum samples collected from the upper back, as in the original study. However, they found that earwax was easier to collect and had a more stable chemical composition. These findings led them to focus on earwax in the current study. Ear wax also contains sebum. But unlike sebum on the surface of the skin, which is exposed to various factors that can degrade it. In contrast, sebum on skin inside the ear canal is protected. Dong's study included 209 participants, 108 of whom had a diagnosis of PD. Ear canal secretions were collected from all participants using swabs and analyzed using gas chromatography-mass spectrometry. Results showed that ear canal secretions from participants with PD contained 196 distinct VOCs compared with 168 VOCs in those without PD. Interestingly, no two participants had identical VOC profiles. A Disease 'Fingerprint'? 'In this case, VOC components could be used as a 'fingerprint' for disease identification,' the researchers wrote. Adjusted analyses identified four VOCs that significantly differed between participants with and without PD: ethylbenzene, 4-ethyltoluene, pentanal, and 2-pentadecyl-1,3-dioxolane. The investigators trained the AIO system using VOC data. By combining gas chromatography-surface acoustic wave sensors with a convolutional neural network (CNN) model, the AIO system achieved up to 94.4% accuracy in distinguishing participants with PD from those without. In addition, the CNN model demonstrated a high level of performance with an area under the curve of 0.98, well above the 0.8 threshold considered strong by the researchers. 'Further enhancements to the diagnostic model could pave the way for a promising new PD diagnostic solution and the clinical use of a bedside PD diagnostic device,' the investigators wrote. For now, Dong said the study's takeaway message for clinicians is that 'the potential of volatile organic compounds secreted by the skin as biomarkers for Parkinson's disease has been further verified.'
New York Post
2 days ago
- New York Post
Living near a golf course is linked to Parkinson's risk in new study as some cite limitations
Advertisement If living near a golf course seems scenic and relaxing, it may also be linked to a higher risk of Parkinson's disease, according to a surprising new study that comes with some limitations. Led by the Barrow Neurological Institute in Arizona, along with Mayo Clinic, the study found that the greatest risk was found among those who live within one to three miles of a golf course. 'The strongest effects were in municipal water service areas with a golf course and in regions with vulnerable groundwater based on the bedrock and topography,' lead study author Brittany Krzyzanowski, Ph.D., assistant professor at the Barrow Neurological Institute, told Fox News Digital. Advertisement 'These findings suggest that pesticides applied to golf courses may play a role in the incidence of PD [Parkinson's disease] for nearby residents,' the researchers concluded in the study, which was published in JAMA Network Open. The case-control study analyzed data from 419 Parkinson's patients averaging 73 years of age and living near 139 golf courses in southern Minnesota and western Wisconsin. They then made comparisons to control data from the Rochester Epidemiology Project from 1991 to 2015. 5 Led by the Barrow Neurological Institute in Arizona, along with the Mayo Clinic, the study found that the greatest risk was among those who live within one to three miles of a golf course. Peakstock – Advertisement 'We had accurate data on golf course locations, and we could accurately determine the source of an individual's drinking water – whether that be municipal water or private well water,' Krzyzanowski noted. Living within one mile of a golf course was associated with 126% increased odds of developing the neurological disease compared to living more than six miles away, the study found. People living near water service areas with a golf course had nearly twice the risk of developing Parkinson's compared with individuals in water service areas without golf courses. Those living in water service areas with a golf course in vulnerable groundwater regions had an 82% higher risk, according to the findings. Advertisement (Vulnerable groundwater is more susceptible to contamination from human activities and environmental factors.) The associations remained even after the researchers adjusted for age and income, which suggests there could be something more than demographics driving the relationship between golf course proximity and risk of Parkinson's disease, Krzyzanowski noted. 'We speculate that pesticides might play a role; however, we didn't include data on pesticides in this study, so future research is needed to better understand what's going on,' she said. 5 The case-control study analyzed data from 419 Parkinson's patients averaging 73 years of age and living near 139 golf courses in southern Minnesota and western Wisconsin. Reese Coop/ – Dr. Mary Ann Picone, medical director of the MS Center at Holy Name Medical Center in Teaneck, New Jersey, was not involved in the study but shared her opinion of the findings. 'There has often been discussion regarding risks for development of Parkinson's disease and environmental agents such as pesticides,' she told Fox News Digital. 'Further research is needed with larger groups of patients, but this study does increase the concern about the association between pesticide exposure and risk of Parkinson's, especially within a one- to three-mile radius and groundwater and well vulnerability.' Airborne exposure to the pesticides was also a factor, she added. Potential limitations Advertisement The main limitation of the study is that it is not possible to quantify the amount of exposure each person receives, according to Dr. Rodolfo Savica, Mayo Clinic neurologist and senior author of the study. 'Unfortunately, there are many other aspects as well that can interfere with developing a disease,' he told Fox News Digital. 'Despite that, we are trying our best to contemplate and adjust for any possible additional information, but sometimes that is not possible.' 5 Living within one mile of a golf course was associated with 126% increased odds of developing the neurological disease compared to living more than six miles away, the study found. ipopba – Advertisement The study was limited to a region with hot and humid summers, specifically southern Minnesota and western Wisconsin, where golf courses may have applied pesticides with more frequency compared to other geographic regions. 'Therefore, our results might not generalize to other areas,' the study lead noted. Other relevant Parkinson's risk factors, such as head trauma history and genetic predisposition, were not accounted for, Picone noted. Krzyzanowski also pointed out that Parkinson's disease develops many decades after exposure, so the study aimed to estimate exposure from long ago. Advertisement 'If pesticides were involved, they would be the ones sprayed a long time ago and that might be different from what's being sprayed today,' she said. 5 The associations remained even after the researchers adjusted for age and income, suggesting that something more than demographics may be driving the relationship between golf course proximity and the risk of Parkinson's disease. Thomas T/ – Picone agreed that because this study looked back to 2013, it is possible that different pesticides used before 2013 were not tracked. 'However, this study does provide evidence for an association between living on a golf course and pesticide groundwater exposure and risk of Parkinson's development, and does raise concern and the need for larger population sample research,' she shared with Fox News Digital. Advertisement Krzyzanowski added that because this was an observational study, the researchers couldn't make causal conclusions about the results. 'If you're worried about exposure of any kind, you should consult with your doctor,' she advised. Industry spokespeople respond A spokesperson from the Golf Course Superintendents Association of America, headquartered in Lawrence, Kansas, provided a statement to Fox News Digital in response to the study. 5 Living within one mile of a golf course was associated with 126% increased odds of developing the neurological disease compared to living more than six miles away, the study found. Pixel-Shot – 'Public health experts and researchers who have reviewed the study have noted that the study's methodological limitations make it difficult to draw conclusions from the data. As noted by the authors of the study, the role of pesticide exposure from golf courses in Parkinson's disease risk remains unclear. Without the methodological gaps being filled, the hypothesis linking golf-course pesticide exposure to Parkinson's Disease remains speculative.' The spokesperson noted that the US Environmental Protection Agency (EPA) rigorously tests and registers the pesticides that the golf industry uses to maintain healthy golf course turf. 'Pesticides registered by the EPA do not, according to the top researchers in their field, create unreasonable adverse effects to human health and the environment when used according to label directions,' the spokesperson continued. 'Golf course superintendents are leading practitioners of integrated pest management, a philosophy that reduces the potential environmental risks of pesticide usage.' Mayo Clinic's Savica recommended that older adults continue to stay active, which is crucial for their well-being. 'I recommend people continue to play sports outdoors and enjoy the sociality of any activity, including playing golf,' he said. 'On the other hand, I would recommend that people be very careful and avoid exposure to places where we know there can be an interaction between pesticides and contaminants.'
